Both semaglutide and Mounjaro fall into the category of GLP-1 receptor agonists, meaning they mimic a hormone that helps regulate blood sugar, digestion, and appetite
Kidney Function Clinical trials found that kidney disorders occurred at similar rates for semaglutide versus comparators, indicating no increased nephrotoxicity
Emerging evidence suggests neuroprotective properties and broader metabolic benefits
Some patients report improvements in sexual function and libido during semaglutide treatment, potentially related to weight loss, improved self-confidence, better glycemic control, and enhanced cardiovascular function
Pattern HED extrapolation ceiling Daily Dose ~650 mg/day Tablet Math (50 mg) 13 tablets/day included only to show the gap with vendor doses Frequency n/a Notes Allometric scaling from 100 mg/kg/day mouse dose to 80 kg human
it is about feeling your best and keeping your body in balance